D.E. Shaw & Co’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-75,900
| Closed | -$47.3K | – | 3087 |
|
|
2025
Q1 | $47.3K | Sell |
75,900
-179,978
| -70% | -$112K | ﹤0.01% | 2888 |
|
|
2024
Q4 | $427K | Sell |
255,878
-34,518
| -12% | -$57.6K | ﹤0.01% | 2474 |
|
|
2024
Q3 | $529K | Buy |
290,396
+271,456
| +1,433% | +$494K | ﹤0.01% | 2451 |
|
|
2024
Q2 | $114K | Buy |
+18,940
| New | +$114K | ﹤0.01% | 2884 |
|
|
2024
Q1 | – | Sell |
-50,178
| Closed | -$747K | – | 3108 |
|
|
2023
Q4 | $747K | Buy |
50,178
+4,496
| +10% | +$66.9K | ﹤0.01% | 2207 |
|
|
2023
Q3 | $219K | Sell |
45,682
-2,525
| -5% | -$12.1K | ﹤0.01% | 2558 |
|
|
2023
Q2 | $362K | Buy |
48,207
+7,132
| +17% | +$53.6K | ﹤0.01% | 2441 |
|
|
2023
Q1 | $186K | Buy |
41,075
+15,152
| +58% | +$68.5K | ﹤0.01% | 2820 |
|
|
2022
Q4 | $292K | Buy |
25,923
+700
| +3% | +$7.89K | ﹤0.01% | 2906 |
|
|
2022
Q3 | $241K | Sell |
25,223
-9,163
| -27% | -$87.6K | ﹤0.01% | 3152 |
|
|
2022
Q2 | $278K | Buy |
+34,386
| New | +$278K | ﹤0.01% | 3267 |
|
|
2021
Q4 | – | Sell |
-7,710
| Closed | -$569K | – | 3951 |
|
|
2021
Q3 | $569K | Sell |
7,710
-38,109
| -83% | -$2.81M | ﹤0.01% | 2783 |
|
|
2021
Q2 | $2.51M | Sell |
45,819
-6,439
| -12% | -$352K | ﹤0.01% | 1916 |
|
|
2021
Q1 | $3.85M | Buy |
52,258
+45,423
| +665% | +$3.35M | ﹤0.01% | 1491 |
|
|
2020
Q4 | $589K | Buy |
+6,835
| New | +$589K | ﹤0.01% | 2225 |
|